Shionogi & Co., Ltd.
Shionogi & Co., Ltd. (SGIOF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
sgiof · pe ratio · data through Mar 31, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Shionogi & Co., Ltd. (SGIOF) measures how much investors pay for each dollar of the company's trailing earnings. SGIOF's current PE ratio of 11.80x is calculated by dividing its stock price of $17.68 by its TTM earnings per share of $241.09. +89.1% elevated vs 5Y avg 6.2x
Source: FMP · /ratios-ttm · /analyst-estimates · 2026-03-31
PE Ratio History
2007 – 2026 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 20 fiscal years · Front-end computedMinQ1 · 25%5.6x
MedianQ3 · 75%13.1x
Max
At 11.80x, SGIOF's current P/E is higher than in 90% of its annual fiscal year readings over the past 20 years — historically elevated.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Shionogi & Co., Ltd.You SGIOF | $15.0B | 11.80x | -80.4% | $241.09 |
 Alibaba Health Information Technology Limited ALBHF | $6.7B | 36.07x | -40.1% | $0.12 |
 Swedish Orphan Biovitrum AB (publ) BIOVF | $16.4B | 234.66x | +289.5% | $1.38 |
 bioMérieux S.A. BMXMF | $9.9B | 32.65x | -45.8% | $3.37 |
 CSPC Pharmaceutical Group Limited CHJTF | $12.0B | 22.34x | -62.9% | $0.33 |
 Fresenius Medical Care AG & Co. KGaA FMCQF | $11.6B | 11.79x | -80.4% | $3.36 |
 Olympus Corporation OCPNF | $12.3B | 24.00x | -60.2% | $61.70 |
Industry Average 6 peers with valid PE | — | 60.25x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2026-03-31Latest FY2026 | 13.10x | $242.62 | +240.6% | |
2025-03-31 FY2025 | 3.84x | $600.98 | -14.4% | |
2024-03-31 FY2024 | 4.49x | $558.32 | +37.4% | |
2023-03-31 FY2023 | 3.27x | $621.31 | -49.8% | |
2022-03-31 FY2022 | 6.50x | $378.75 | +18.0% | |
2021-03-31 FY2021 | 5.51x | $365.02 | +24.4% | |
2020-03-31 FY2020 | 4.43x | $395.71 | -14.1% | |
2019-03-31 FY2019 | 5.16x | $438.47 | -4.0% | |
2018-03-31 FY2018 | 5.37x | $342.71 | -27.8% | |
2017-03-31 FY2017 | 7.44x | $259.87 | -6.1% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Shionogi & Co., Ltd. (SGIOF) measures how much investors pay for each dollar of the company's trailing earnings. SGIOF's current PE ratio of 11.80x is calculated by dividing its stock price of $17.68 by its TTM earnings per share of $241.09.
Frequently asked questions
SGIOF pe ratio · 6 questionsSGIOF's current PE ratio is 11.80x as of 2026-06-08, based on a stock price of $17.68 and TTM EPS of $241.09. Data sourced from Financial Modeling Prep via SGIOF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Shionogi & Co., Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08